Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, February 13, 2023
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
[ Mon, Feb 13th 2023
] - WOPRAI
Mike Matson Downgraded (SRDX) to Hold on, Feb 13th, 2023
Mike Matson of Needham, Downgraded "Surmodics, Inc." (SRDX) to Hold on, Feb 13th, 2023.
Mike has made no other calls on SRDX in the last 4 months.
There is 1 other peer that has a rating on SRDX. Out of the 1 peers that are also analyzing SRDX, 0 agree with Mike's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mike
- Michael Petusky of "Barrington Research" Maintained at Buy with Decreased Target to $60 on, Tuesday, February 7th, 2023
